Abstract
Quantification of local similarity between protein 3D structures is a promising tool in computer-aided drug design and prediction of biological function. Over the last ten years, several computational methods were proposed, mostly based on geometrical comparisons. This review summarizes the recent literature and gives an overview of available programs. A particular interest is given to the underlying methodologies. Our analysis points out strengths and weaknesses of the various approaches. If all described methods work relatively well when two binding sites obviously resemble each other, scoring potential solutions remains a difficult issue, especially if the similarity is low. The other challenging question is the protein flexibility, which is indeed difficult to evaluate from a static representation. Last, most of recently developed techniques are fast and can be applied to large amounts of data. Examples were carefully chosen to illustrate the wide applicability domain of the most popular methods: detection of common structural motifs, identification of secondary targets for a drug-like compound, comparison of binding sites across a functional family, comparison of homology models, database screening.
Keywords: Local similarity, three-dimensional comparison, protein structure, binding site, molecular shape, drug design, function assignment
Current Computer-Aided Drug Design
Title: How to Measure the Similarity Between Protein Ligand-Binding Sites?
Volume: 4 Issue: 3
Author(s): Esther Kellenberger, Claire Schalon and Didier Rognan
Affiliation:
Keywords: Local similarity, three-dimensional comparison, protein structure, binding site, molecular shape, drug design, function assignment
Abstract: Quantification of local similarity between protein 3D structures is a promising tool in computer-aided drug design and prediction of biological function. Over the last ten years, several computational methods were proposed, mostly based on geometrical comparisons. This review summarizes the recent literature and gives an overview of available programs. A particular interest is given to the underlying methodologies. Our analysis points out strengths and weaknesses of the various approaches. If all described methods work relatively well when two binding sites obviously resemble each other, scoring potential solutions remains a difficult issue, especially if the similarity is low. The other challenging question is the protein flexibility, which is indeed difficult to evaluate from a static representation. Last, most of recently developed techniques are fast and can be applied to large amounts of data. Examples were carefully chosen to illustrate the wide applicability domain of the most popular methods: detection of common structural motifs, identification of secondary targets for a drug-like compound, comparison of binding sites across a functional family, comparison of homology models, database screening.
Export Options
About this article
Cite this article as:
Kellenberger Esther, Schalon Claire and Rognan Didier, How to Measure the Similarity Between Protein Ligand-Binding Sites?, Current Computer-Aided Drug Design 2008; 4 (3) . https://dx.doi.org/10.2174/157340908785747401
DOI https://dx.doi.org/10.2174/157340908785747401 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
An Urgent Industrial Scheme Both for Total Synthesis, and for
Pharmaceutical Analytical Analysis of Umifenovir as an Anti-viral API
for Treatment of COVID-19
Combinatorial Chemistry & High Throughput Screening The Safety of Bisphosphonate Use in Premenopausal Women on Corticosteroids
Current Drug Safety Sequence Analysis, Structure Prediction of Receptor Proteins and <i>In Silico</i> Study of Potential Inhibitors for Management of Life Threatening COVID-19
Letters in Drug Design & Discovery DNA Microarrays - An Armory for Combating Infectious Diseases in the New Century
Infectious Disorders - Drug Targets Serum Interleukin-33 as a Biomarker in Predicting Neonatal Sepsis in Premature Infants
Combinatorial Chemistry & High Throughput Screening The Medical Potential of Antimicrobial Peptides from Insects
Current Topics in Medicinal Chemistry Preparation of Hymenialdisine, Analogues and Their Evaluation as Kinase Inhibitors
Current Medicinal Chemistry Importance of Metabolic Activation Study to the Safe Use of Chinese Herbal Medicines
Current Drug Metabolism The Nature of Protein Domain Evolution: Shaping the Interaction Network
Current Genomics Inhibition of HIV-1 by Fusion Inhibitors
Current Pharmaceutical Design Peptide Ligands for the Melanin-Concentrating Hormone (MCH) Receptor 1
Current Topics in Medicinal Chemistry Can we Succeed in the Fight Against SARS-CoV-2 with its Emerging New Variants?
Current Pharmaceutical Design Electrochemical Reactions as an Efficient Methodology for the Synthesis of Organic Compounds
Current Organic Synthesis SARS-COV-2 in Type 2 Diabetic Patients: Possible Roles of Exercise Training as a Medicine
Current Diabetes Reviews Searching for Potential HDAC2 Inhibitors: Structure-activity Relationship Studies on Indole-based Hydroxamic Acids as an Anticancer Agent
Letters in Drug Design & Discovery COVID-19 Effects on Geriatric Population and Failures of Aminoquinoline Therapy: Compilation of Studies from EU, USA, and China; Safety and Efficacy of Vaccines in the Prevention and Treatment of COVID-19
Current Medicinal Chemistry A Review on Leukemia and iPSC Technology: Application in Novel Treatment and Future
Current Stem Cell Research & Therapy Glycoconjugates As Vaccines for Cancer Immunotherapy: Clinical Trials and Future Directions
Anti-Cancer Agents in Medicinal Chemistry 5-Nitro-Thiophene-Thiosemicarbazone Derivatives Present Antitumor Activity Mediated by Apoptosis and DNA Intercalation
Current Topics in Medicinal Chemistry AMPA Glutamate Receptors and Neuropathic Pain
Mini-Reviews in Medicinal Chemistry